Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda

Source :: Tuberculosis Week. August 26, 2024, 20
Publication Year :: 2024
Abstract: 2024 AUG 26 (NewsRx) -- By a News Reporter-Staff News Editor at Tuberculosis Week -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Subjects :: HIV (Viruses) -- Drug therapy -- Complications and side effects -- Prevention
Tuberculosis -- Prevention -- Complications and side effects -- Drug therapy
HIV patients -- Drug therapy
Rifamycins -- Complications and side effects
Rifapentine -- Complications and side effects
Health

Tools